March 31, 2025 03:57 PM EDTUpdated 04:07 PM
Pharma
Cell/Gene Tx
Law

DC court sides with HHS in Ver­tex's fer­til­i­ty pro­gram fight

Nicole DeFeudis

Editor

Ver­tex lost a le­gal bat­tle against the fed­er­al gov­ern­ment on Mon­day over its pro­posed fer­til­i­ty sup­port pro­gram that would have of­fered up to $70,000 in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

Cari­bou lays off 32% of staff, cuts lu­pus cell ther­a­py pro­gram be­fore first pa­tient

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times